author-photo

Kazuo Tsubaki

Kindai University

86

Papers

1278

Citations

Citation Trend

Filter By

Papers (61) Sort By

Journal Conference Others

Incidence of acute kidney disease after receiving hematopoietic stem cell transplantation: a single-center retrospective study

2019 PeerJ
Show All
- Source
- Cite
- Save
Citations (7)
〈Original〉Quality of life of chronic myelogenous leukemia patients following BCR-ABL inhibitor therapy: A multicenter study in Nara Japan using SF-8

2019
Show All
- Source
- Cite
- Save
Citations (0)
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

2018 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (62)
Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms

2017 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (15)
Successful Third Hematopoietic Stem Cell Transplantation for Blast Crisis of Chronic Myeloid Leukemia After Two Times of Graft Failure

2017
Show All
- Source
- Cite
- Save
Citations (0)
Once-weekly Bortezomib in Combination with Reduced-dose Dexamethasone and Continuous Low-dose Oral Cyclophosphamide for Elderly Patients with Multiple Myeloma

2017 Journal of Hematology and Thromboembolic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Transfusion and Apheresis Science

2014
Show All
- Source
- Cite
- Save
Citations (0)
Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)
〈Cases Reports〉Successful treatment with intravenous colistin of sepsis caused by metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in a patient with acute myeloid leukemia

2014
Show All
- Source
- Cite
- Save
Citations (0)
Reduced-Dosage Of Three Drugs Combination Of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Is Suitable For Elderly Frail Patients With Multiple Myeloma

2013 Blood
Show All
- Source
- Cite
- Save
Citations (1)